News
-
Results of The Migraine Trust’s latest patient survey to inform new migraine drug NICE consultation
NICE opened the public consultation as it announced its initial decision is to not recommend Ajovy be made available on the NHS to treat migraine
Read more -
Update on NHS appraisals for CGRP medication
Activity since NICE rejected Aimovig for use on the NHS in England and Wales
Read more -
Migraine community survey launches
This is an important opportunity to share your experience and views
Read more -
NICE rejects Aimovig as a migraine treatment in NHS England
The Migraine Trust is concerned about health inequalities and a postcode lottery for people with migraine in the UK
Read more
